Your browser doesn't support javascript.
loading
SARS-CoV-2 Infection among Medical Institution Faculty and Healthcare Workers in Tokyo, Japan.
Nishimura, Tomoyasu; Uwamino, Yoshifumi; Uno, Shunsuke; Kashimura, Shoko; Shiraki, Toshikimi; Kurafuji, Toshinobu; Morita, Maasa; Noguchi, Masayo; Azegami, Tatsuhiko; Yamada-Goto, Nobuko; Murai-Takeda, Ayano; Yokoyama, Hirokazu; Kuwabara, Kazuyo; Kato, Suzuka; Matsumoto, Minako; Hirata, Aya; Iida, Miho; Harada, Sei; Ishizaka, Tamami; Misawa, Kana; Murata, Mitsuru; Saya, Hideyuki; Amagai, Masayuki; Kitagawa, Yuko; Takeuchi, Tsutomu; Mori, Masaaki; Takebayashi, Toru; Hasegawa, Naoki.
Afiliação
  • Nishimura T; Keio University Health Center, Japan.
  • Uwamino Y; Department of Infectious Diseases, Keio University School of Medicine, Japan.
  • Uno S; Department of Infectious Diseases, Keio University School of Medicine, Japan.
  • Kashimura S; Department of Laboratory Medicine, Keio University School of Medicine, Japan.
  • Shiraki T; Department of Infectious Diseases, Keio University School of Medicine, Japan.
  • Kurafuji T; Department of Infectious Diseases, Keio University School of Medicine, Japan.
  • Morita M; Department of Laboratory Medicine, Keio University School of Medicine, Japan.
  • Noguchi M; Department of Laboratory Medicine, Keio University School of Medicine, Japan.
  • Azegami T; Department of Laboratory Medicine, Keio University School of Medicine, Japan.
  • Yamada-Goto N; Department of Laboratory Medicine, Keio University School of Medicine, Japan.
  • Murai-Takeda A; Keio University Health Center, Japan.
  • Yokoyama H; Keio University Health Center, Japan.
  • Kuwabara K; Keio University Health Center, Japan.
  • Kato S; Keio University Health Center, Japan.
  • Matsumoto M; Department of Preventive Medicine and Public Health, Keio University School of Medicine, Japan.
  • Hirata A; Department of Preventive Medicine and Public Health, Keio University School of Medicine, Japan.
  • Iida M; Department of Preventive Medicine and Public Health, Keio University School of Medicine, Japan.
  • Harada S; Department of Preventive Medicine and Public Health, Keio University School of Medicine, Japan.
  • Ishizaka T; Department of Preventive Medicine and Public Health, Keio University School of Medicine, Japan.
  • Misawa K; Department of Preventive Medicine and Public Health, Keio University School of Medicine, Japan.
  • Murata M; Department of Infectious Diseases, Keio University School of Medicine, Japan.
  • Saya H; Department of Infectious Diseases, Keio University School of Medicine, Japan.
  • Amagai M; Division of Pharmacodynamics, Keio University Faculty of Pharmacy, Japan.
  • Kitagawa Y; Department of Laboratory Medicine, Keio University School of Medicine, Japan.
  • Takeuchi T; Institute for Advanced Medical Research, Keio University School of Medicine, Japan.
  • Mori M; Department of Dermatology, Keio University School of Medicine, Japan.
  • Takebayashi T; Department of Surgery, Keio University School of Medicine, Japan.
  • Hasegawa N; Division of Rheumatology, Department of Medicine, Keio University School of Medicine, Japan.
Intern Med ; 60(16): 2569-2575, 2021 Aug 15.
Article em En | MEDLINE | ID: mdl-34148952
ABSTRACT
Objective To consider effective measures against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in medical institutions, this study estimated the SARS-CoV-2 infection rate among healthcare workers (HCWs) in Tokyo, Japan, and determined the specific findings for mild coronavirus disease 2019 (COVID-19) cases. Methods This study analyzed the results of serologic tests to detect immunoglobulin G antibodies against SARS-CoV-2 and evaluated the demographic and clinical characteristics of the faculty and HCWs at a Tokyo medical institution in August 2020. The demographic and clinical characteristics of participants with antibody-positive results were compared to those of participants with antibody-negative results. Materials This study recruited 2,341 faculty and HCWs at a Tokyo medical institution, 21 of whom had a COVID-19 history. Results Of the 2,320 participants without a COVID-19 history, 20 (0.862%) had positive serologic test results. A fever and dysgeusia or dysosmia occurred with greater frequency among the participants with positive test results than in those with negative results [odds ratio (OR), 5.475; 95% confidence interval (CI), 1.960-15.293 and OR, 24.158; 95% CI, 2.693-216.720, respectively]. No significant difference was observed in the positivity rate between HCWs providing medical care for COVID-19 patients using adequate protection and other HCWs (OR, 2.514; 95% CI, 0.959-6.588). Conclusion To reduce the risk of COVID-19 spread in medical institutions, faculty and HCWs should follow standard and necessary transmission-based precautions, and those with a fever and dysgeusia or dysosmia should excuse themselves from work as soon as possible.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: SARS-CoV-2 / COVID-19 Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: SARS-CoV-2 / COVID-19 Idioma: En Ano de publicação: 2021 Tipo de documento: Article